Rapid 4 to 6 hour detection of extended-spectrum beta-lactamases in a routine laboratory

Scandinavian Journal of Infectious Diseases

Volumn 39, Issue 9, 2007, Pages 781-785

  Ercis, Serpil ^a   Sancak, Banu ^a   Kocagöz, Tanil ^b,c,d   Kocagöz, Sesin ^b   Hasçelik, Gülşen ^a   Bolmström, Anne ^e  

^a HACETTEPE UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

^c Turkish Innovative Biotechnology Organization   (Turkey)

^d Salubris Inc   (Turkey)

^e AB BIODISK   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CEFEPIME; CEFTAZIDIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE;

ANALYTIC METHOD; ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIUM DETECTION; CONTROLLED STUDY; CULTURE MEDIUM; DIFFUSION; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENZYME ANALYSIS; ENZYME ASSAY; ESCHERICHIA COLI; GENOTYPE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; INTERMETHOD COMPARISON; ISOELECTRIC FOCUSING; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RELIABILITY; SERRATIA MARCESCENS; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; TIME; VALIDATION STUDY;

AGAR; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CROSS INFECTION; DISK DIFFUSION ANTIMICROBIAL TESTS; ENTEROBACTERIACEAE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS;

EID: 34548136641     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701367751     Document Type: Article

References (22)

1. Jarlier, V., Nicolas, MH, Fournier, G. and Philippon, A. (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility pattern. Rev Infect Dis, 10, pp. 867-878.
2. Shah, PW and Stille, W. (1983) Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins. J Antimicrobiol Chemother, 11, pp. 597-598.
3. Jacoby, GA, Medeiros, AA, O'Brien, TF, Pinto, ME and Jiang, H. (1988) Broad-spectrum, transmissible beta-lactamases. N Engl J Med, 319, pp. 723-724.
4. Quinn, JP, Miyashiro, D., Sahm, D., Flamm, R. and Bush, K. (1989) Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother, 33, pp. 1451-1456.
5. Diekema, DJ, Pfaller, MA, Jones, RN, Doem, GV, Winokur, PL and Gales, AC (1999) Survey of bloodstream infections due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program 1997. Clin Infect Dis, 29, pp. 595-607.
6. MacKenzie, FM, Miller, CA and Gould, IM. (2002) Comparison of screening methods for TEM- and SHV- derived extended-spectrum beta-lactamase detection. Clin Microbiol Infect, 8, pp. 715-724.
7. Philippon, A., Arlet, G. and Lagrance, PH. (1994) Origin and impact of plasmid-mediated extended- spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis, 13, pp. 17-29.
8. Çaǎatay, AA, Kocagöz, T. and Eraksoy, H. (2003) Dio-sensimedia: A novel culture medium for rapid detection of extended-spectrum beta-lactamases. BMC Infectious Diseases, 3, p. 22.
9. Kocagöz, T., Ercis, S., Darka, Ö, Salmanzadeh-Ahrabi, S., Kocagöz, S. and Hasçelik, G. (2007) Quicolor: A novel system for rapid antibacterial susceptibility testing. Ann Microbiol, 57, pp. 131-135.
10. Clinical and Laboratory Standards Institute (formerly NCCLS) (2005) Performance Standards for Antimicrobial susceptibility Testing; Fifteenth Informational Supplement: M100-S15. CLSI, CLSI, Wayne, PA, USA
11. Eckert, C., Gautier, V., Saladin-Allard, M., Hidri, N., Verdet, C. and Ould-Hocine, Z. (2004) Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother, 48, pp. 1249-1255.
12. Muratani, T., Kobayashi, T. and Matsumoto, T. (2006) Emergence and prevalence of beta-lactamase-producing Klebsiella pneumoniae resistant to cephems in Japan. Int J Antimicrob Agents, 27, pp. 491-499.
13. Barenfanger, J., Drake, C. and Kacich, G. (1999) Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol, 37, pp. 1415-1418.
14. Doern, G., Vautour, R., Gaudet, M. and Levy, B. (1994) Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol, 32, pp. 1757-1762.
15. Schifman, R., Pindur, A. and Bryan, JA. (1997) Laboratory practices for reporting bacterial susceptibility tests that affect antibiotic therapy. Arch Pathol Lab Med, 121, pp. 1168-1170.
16. Granato, PA. (1993) Impact of same-day tests versus traditional overnight testing. Diagn Microbiol Infect Dis, 16, pp. 237-243.
17. Livermore, DM. (1995) Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev, 8, pp. 557-584.
18. Matar, GM, Khodor, S Al, El-Zaatari, M. and Uwaydah, M. (2005) Prevalence of the genes encoding extended-spectrum beta-lactamases, in Escherichia coli resistant to beta-lactam and non-beta-lactam antibiotics. Ann Trop Med Parasitol, 99, pp. 413-417.
19. Ho, PL, Ho, AY, Chow, KH, Wong, RC, Duan, RS and Ho, WL (2005) Occurrence and molecular analysis of extended-spectrum beta-lactamase-producing Proteus mirabilis in Hong Kong, 1999-2002. J Antimicrob Chemother, 55, pp. 840-845.
20. D'Azevedo, PA, Goncalves, AL, Musskopf, MI, Ramos, CG and Dias, CA. (2004) Laboratory tests in the detection of extended-spectrum beta-lactamase production: National Committee for Clinical Laboratory Standards (NCCLS) screening test, the E-test, the double disk confirmatory test, and cefoxitin susceptibility testing. Braz J Infect Dis, 8, pp. 372-377.
21. Linscott, AJ and Brown, WJ. (2005) Evaluation of 4 commercially available extended-spectrum beta-lactamase phenotypic confirmation tests. J Clin Microbiol, 43, pp. 1081-1085.
22. Sturenburg, E., Sobottka, I., Noor, D., Laufs, R. and Mack, D. (2004) Evaluation of a new cefepime-clavulanate ESBL E-test to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection. J Antimicrob Chemother, 54, pp. 134-138.